uploads/2016/06/Part-5-Graph-06-08-16-1.png

How Are XBI’s Holdings’ Moving Averages Trending?

By

Updated

XBI’s moving averages

The SPDR S&P Biotech ETF (XBI) has 86 stocks in its portfolio. On June 8, 2016, 77% of XBI’s stocks were trading above their 20-day moving averages, 69% were trading above their 50-day moving averages, and 69% were trading above their 100-day moving averages.

The above graph shows the percentage of XBI’s holdings and their moving averages on June 8, 2016. Of XBI’s 86 stocks, 66 were trading above their 20-day moving averages, 59 were trading above their 50-day moving averages, and 59 were trading above their 100-day moving averages.

Article continues below advertisement

What is XBI’s moving average trend?

On June 8, 2016, XBI closed at $58.69 and was trading above its 20-day, 50-day, and 100-day moving averages. XBI’s 20-day moving average was $55.10. On June 1, 2016, its 20-day moving average was $53.40, indicating an upward trend.

A few XBI stocks are trading above their 20-day and 100-day moving averages

Incyte (INCY), Juno Therapeutics (JUNO), Intercept Pharmaceuticals (ICPT), and Kite Pharma (KITE) are a few of XBI’s 66 stocks that are trading above their 20-day moving averages. Let’s take a look at these stocks’ 100-day moving averages.

The XBI stocks trading above their 20-day moving averages:

  • Incyte: $76.70 on June 1, 2016, and $80.10 on June 8, 2016
  • Juno Therapeutics: $39.30 on June 1, 2016, and $41.50 on June 8, 2016
  • Intercept Pharmaceuticals: $137.80 on June 1, 2016, and $144.60 on June 8, 2016
  • Kite Pharma: $46.00 on June 1, 2016, and $48.70 on June 8, 2016

All four stocks showed upward trends.

The XBI stocks trading above their 100-day moving averages are:

  • Incyte: $74.30 on June 1, 2016, and $74.20 on June 8, 2016
  • Juno Therapeutics: $37.20 on June 1, 2016, and $37.80 on June 8, 2016
  • Intercept Pharmaceuticals: $128.30 on June 1, 2016, and $130.30 on June 8, 2016
  • Kite Pharma: $47.70 on June 1, 2016, $47.80 on June 8, 2016

With the exception of Incyte, all the above-mentioned stocks have shown upward trends.

Moving averages help investors to identify price trends and compare stocks’ current prices with their various moving average prices. This can help investors to identify support and resistance levels and make informed investment decisions.

Advertisement

More From Market Realist